Skip to main content

Oseltamivir Oral Suspension and Capsules Shortage

Last Updated: May 25, 2025
Status: Current

Products Affected - Description
    • Oseltamivir oral capsule, Alvogen, 30 mg, unit-dose blister pack, 10 count, NDC 47781-0468-13
    • Oseltamivir oral capsule, Alvogen, 45 mg, unit-dose blister pack, 10 count, NDC 47781-0469-13
    • Oseltamivir oral capsule, Alvogen, 75 mg, unit-dose blister pack, 10 count, NDC 47781-0470-13
    • Oseltamivir oral powder for suspension, Alvogen, 6 mg/mL, 60 mL bottle, 1 count, NDC 47781-0384-26
    • Oseltamivir oral powder for suspension, Amneal, 6 mg/mL, 60 mL bottle, 1 count, NDC 69238-1273-06
    • Oseltamivir oral powder for suspension, Teva, 6 mg/mL, 60 mL bottle, 1 count, NDC 00093-8180-64
Reason for the Shortage
    • Ajanta has oseltamivir available to contracted customers.
    • Alembic has oseltamivir available.
    • Alvogen did not provide a reason for the shortage.
    • Amneal did not provide a reason for the powder for suspension shortage. Amneal discontinued their oseltamivir capsule presentations.
    • Camber has oseltamivir available.
    • Genentech has Tamiflu presentations available.
    • Lupin has oseltamivir available.
    • Macleods has oseltamivir capsules available.
    • Novadoz has oseltamivir available.
    • Strides has oseltamivir capsules available.
    • Teva did not provide a reason for the shortage.
    • Zydus has oseltamivir suspension available.
Available Products
    • Tamiflu oral capsule, Genentech, 30 mg, unit-dose blister pack, 10 count, NDC 00004-0802-85
    • Tamiflu oral capsule, Genentech, 45 mg, unit-dose blister pack, 10 count, NDC 00004-0801-85
    • Tamiflu oral capsule, Genentech, 75 mg, unit-dose blister pack, 10 count, NDC 00004-0800-85
    • Tamiflu oral powder for suspension, Genentech, 6 mg/mL, 60 mL bottle, 1 count, NDC 00004-0822-05
    • Oseltamivir oral powder for suspension, Ajanta, 6 mg/mL, 60 mL bottle, 1 count, NDC 27241-0139-09
    • Oseltamivir oral capsule, Alembic, 30 mg, unit-dose blister pack, 10 count, NDC 62332-0413-10
    • Oseltamivir oral capsule, Alembic, 45 mg, unit-dose blister pack, 10 count, NDC 62332-0414-10
    • Oseltamivir oral capsule, Alembic, 75 mg, unit-dose blister pack, 10 count, NDC 62332-0415-10
    • Oseltamivir oral capsule, Camber, 30 mg, unit-dose blister pack, 10 count, NDC 31722-0630-31
    • Oseltamivir oral capsule, Camber, 45 mg, unit-dose blister pack, 10 count, NDC 31722-0631-31
    • Oseltamivir oral capsule, Camber, 75 mg, unit-dose blister pack, 10 count, NDC 31722-0632-31
    • Oseltamivir oral capsule, Lupin, 30 mg, unit-dose blister pack, 10 count, NDC 68180-0675-11
    • Oseltamivir oral capsule, Lupin, 45 mg, unit-dose blister pack, 10 count, NDC 68180-0676-11
    • Oseltamivir oral capsule, Lupin, 75 mg, unit-dose blister pack, 10 count, NDC 68180-0677-11
    • Oseltamivir oral powder for suspension, Lupin, 6 mg/mL, 60 mL bottle, 1 count, NDC 68180-0678-01
    • Oseltamivir oral capsule, Macleods, 30 mg, unit-dose blister pack, 10 count, NDC 33342-0256-66
    • Oseltamivir oral capsule, Macleods, 45 mg, unit-dose blister pack, 10 count, NDC 33342-0257-66
    • Oseltamivir oral capsule, Macleods, 75 mg, unit-dose blister pack, 10 count, NDC 33342-0258-66
    • Oseltamivir oral capsule, Novadoz, 30 mg, unit-dose blister pack, 10 count, NDC 72205-0042-11
    • Oseltamivir oral capsule, Novadoz, 45 mg, unit-dose blister pack, 10 count, NDC 72205-0043-11
    • Oseltamivir oral capsule, Novadoz, 75 mg, unit-dose blister pack, 10 count, NDC 72205-0044-11
    • Oseltamivir oral capsule, Strides Pharma, 30 mg, unit-dose blister pack, 10 count, NDC 64380-0797-01
    • Oseltamivir oral capsule, Strides Pharma, 45 mg, unit-dose blister pack, 10 count, NDC 64380-0798-01
    • Oseltamivir oral capsule, Strides Pharma, 75 mg, unit-dose blister pack, 10 count, NDC 64380-0799-01
    • Oseltamivir oral powder for suspension, Zydus, 6 mg/mL, 60 mL bottle, 1 count, NDC 70710-1165-06

Estimated Resupply Dates

    • Alvogen has all oseltamivir presentations on back order and the company cannot estimate a release date.
    • Amneal will relaunch oseltamivir 6 mg/mL powder for suspension at a later date.
    • Teva has oseltamivir 6 mg/mL powder for suspension on intermittent back order and the company is releasing product as it becomes available.

Implications for Patient Care

    • FDA has provided contact numbers for suppliers of oseltamivir and other antivirals to help with the shortage. Per FDA, this shortage is more local stock outs due to increased demand. More information can be found at: https://www.fda.gov/media/120654/download

Alternative Agents & Management

    • CDC has interim guidance for the oseltamivir shortage. The guidelines can be found at: https://emergency.cdc.gov/han/2022/han00482.asp.

Updated

Updated May 25, 2025 by Elyse MacDonald, PharmD, MS, BCPS. Created November 1, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer